We are live on
!
Find out more
BIA
Biondo Investment Advisors Portfolio holdings
AUM
$780M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
+7.51%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.27%
AUM
$600M
AUM Growth
+$17.4M
(+3%)
Cap. Flow
-$111M
Cap. Flow
% of AUM
-18.53%
Top 10 Holdings %
Top 10 Hldgs %
46.91%
Holding
88
New
3
Increased
52
Reduced
18
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unity
U
|
+$1.21M |
| 2 |
Coinbase
COIN
|
+$768K |
| 3 |
Bristol-Myers Squibb
BMY
|
+$520K |
| 4 |
Verizon
VZ
|
+$379K |
| 5 |
Lockheed Martin
LMT
|
+$372K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$100M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$10.5M |
| 3 |
Idexx Laboratories
IDXX
|
+$2.01M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$1.84M |
| 5 |
Teladoc Health
TDOC
|
+$1.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.14% |
| 2 | Technology | 22.3% |
| 3 | Financials | 10.98% |
| 4 | Consumer Discretionary | 10.02% |
| 5 | Communication Services | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares Core S&P US Growth ETF
IUSG
$33.7B
| $347K | 0.06% |
3,002
+315
| +12% | +$35.1K |
|
77
Visa
V
$677B
| $305K | 0.05% |
1,405
-5
| -0.4% | -$1.07K |
|
78
Invesco QQQ Trust
QQQ
$484B
| $298K | 0.05% |
750
| – | – |
|
|
BNY
79
Bank of New York Mellon
BNY
$107B
| $232K | 0.04% |
4,000
| – | – |
|
80
PNC Financial Services
PNC
$101B
| $202K | 0.03% |
+1,007
| New | +$205K |
|
81
Energy Transfer Partners
ET
$69.3B
| $200K | 0.03% |
23,460
| – | – |
|
82
Align Technology
ALGN
$12.3B
| – | – |
-650
| Closed | -$433K |
|
83
Boston Omaha
BOC
$436M
| – | – |
-9,650
| Closed | -$374K |
|
84
Doximity
DOCS
$4.88B
| – | – |
-2,925
| Closed | -$236K |
|
|
MCI
85
Barings Corporate Investors
MCI
$345M
| – | – |
-13,000
| Closed | -$202K |
|
86
10x Genomics
TXG
$6.61B
| – | – |
-1,900
| Closed | -$277K |
|
|
RETA
87
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| – | – |
-104,120
| Closed | -$10.5M |
|
Similar funds
LA
SG
RTM
QCMNJ
TIS
MO
NCM
PC
Biondo Investment Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Biondo Investment Advisors held 88 positions worth $600M, up 3% from $583M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Biondo Investment Advisors withdrew a net $111M in Q4 2021, closing 6 positions and reducing 18 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 36% a quarter earlier, followed by Technology and Financials.
Against the trend, Biondo Investment Advisors opened a new position in Unity worth $1.14M.
- Biondo Investment Advisors's largest Q4 2021 buy was Unity: 7,945 shares worth $1.14M.
- Biondo Investment Advisors added most to Bristol-Myers Squibb in Q4 2021, an estimated $520K increase.
- Biondo Investment Advisors's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $100M.
- Biondo Investment Advisors fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $10.5M.
- Biondo Investment Advisors's ten largest holdings make up 47% of its $600M portfolio in Q4 2021.
- Biondo Investment Advisors opened 3 new positions and closed 6 in Q4 2021.
- Biondo Investment Advisors's portfolio value rose 3% quarter-over-quarter to $600M.
Based on Biondo Investment Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.